[STDs Trending] Beware of Prolonged STD Infections Caused by AMR Ureaplasma!

MetaboScreen has discovered that a large number of Ureaplasma cases—an STD known for being difficult to treat—possess drug-resistance genes.

📋 Article Processing Timeline

  • 📰 Published: March 27, 2026 at 23:58
  • 🔍 Collected: March 28, 2026 at 21:59 (22h 1m after Published)
  • 🤖 AI Analyzed: April 15, 2026 at 01:13 (411h 13m after Collected)

In recent years, "Ureaplasma infection," which has been spreading significantly, has become a major issue in clinical settings as one of the sexually transmitted diseases (STDs) that is difficult to cure completely.

Therefore, our laboratory selected Ureaplasma spreading in the community as a research subject and analyzed genes known to affect the efficacy of various antibacterial drugs. As a result, it was confirmed that in the vast majority of Ureaplasma-positive specimens collected by our laboratory, genetic mutations (Antimicrobial Resistance, AMR) that render drugs ineffective have occurred.

Ureaplasma is known as a difficult STD to treat. We expect that the insights gained by our laboratory this time will lead to the realization of effective Ureaplasma treatments that were previously unavailable.

Overview

Our laboratory provides "free testing" for 1,000 people per year targeting risk groups. This research is conducted using positive specimens from participants who agreed to their use for research purposes through this "free testing."

This time, we selected "Ureaplasma," which has a high overall positivity rate and is problematic in treatment settings, as our research subject. We are reporting the results of our analysis on the prevalence of "drug-resistance genes" that cause antibacterial drugs to lose their effectiveness.

Here, "Antimicrobial Resistance (AMR)" refers to the phenomenon where antibacterial drugs that were previously effective no longer work. Due to the overuse of antibacterial drugs over many years, pathogens have evolved to neutralize them. AMR is progressing in many infections beyond just STDs, and some predictions suggest that by 2050, more people will die from drug-resistant bacteria than from cancer. It is a terrifying phenomenon where a disease that should have been easily cured changes into a fatal pathogen that cannot be treated at all, and AMR in STDs is progressing through the exact same mechanism.

AMR is being highlighted as a global issue.

Reference: Antimicrobial Resistance | Japan WHO Association

Reference: Antimicrobial Resistance (AMR) Measures | Ministry of Health, Labour and Welfare

Our Laboratory's Initiatives

Our laboratory conducts free STD testing for 1,000 people annually, hoping to deepen interest in and knowledge of STDs by having people experience the testing process.

Campaign details can be found at...